medigraphic.com
ISSN 1561-3119 (Electronic)

2017, Number 2

<< Back Next >>

Rev Cubana Pediatr 2017; 89 (2)

Influence of the regulating factors of short-term control of appetite and satiety on energy balance

Basain VJM, Valdés AMC, Pérez MM, Marrero RRM, Martínez IA, Mesa MI

Language: Spanish
References: 29
Page: 187-202
PDF size: 418.79 Kb.


ABSTRACT

Introduction: Steady level of stored energy is kept thanks to regulating factors of appetite and satiety which also influence on the state of energy balance.
Objective: To describe the influence of regulating factors of appetite and satiety at short-term on the energy balance.
Methods: A literature search was made in Medline/PubMed, Bireme, DOYMA editions and Elsevier to find English and Spanish articles in the period of January 1973 to June 2016. The search terms were food intake, "energy balance", "regulation", "nutritional homeostasis".
Development: Food intake is human behavior resulting from the complex interaction of multiple factors, being the most important the physiological ones and at the humoral level, the role of ghrelina in the onset of intake is well-established. At the same time, various organs set in motion to fix the moment when one should stop eating, a mechanism in which several hormones are involved such as cholecystokinin, a peptide similar to type 1 glycagon, oxyntomodulin, peptide YY, bombesin, enterostatin, amyline and pancreatic polypeptide.
Final thoughts: There are several mechanisms involved in the regulation of the short-term control of appetite and satiety which are closely related, have an effect on and determine the state of the energy balance.


REFERENCES

  1. Valladares M, Obregón AM, Weisstaub G, Burrows R, Patiño A, Ho-Urriola J, et al. Asociación entre la conducta alimentaria y polimorfismos genéticos de la leptina y su receptor en niños obesos chilenos. Nutr Hosp. 2015;31(3):1044-51.

  2. Phillips C. Nutrigenetics and Metabolic Disease: Current status and implications for personalized nutrition. Nutrients. 2013;5:32-57.

  3. Quintero Y, Bastardo G, Angarita C. La nutrición molecular y sus aportes al estudio de la obesidad. Rev Venez Endocrinol Metab. 2015;13(1):14-24.

  4. Rodríguez C, Quezada-Feijoo M, Toro C, Barón-Esquivias G, Segura E, Mangas A, et al. Comportamiento del eje entero-insular en una población deportista; influencia de la dieta y el ejercicio. Nutr Hosp. 2015;31(5):2187-94.

  5. Hernández Rodríguez J, Licea Puig ME, Castelo Elías-Calles L. Medicamentos que favorecen la pérdida de peso y el control metabólico en las personas obesas con diabetes mellitus tipo 2. Rev Cubana Endocrinol. 2013;24(2):323-52.

  6. Rodríguez E, López B, López AM, Ortega RM. Prevalencia de sobrepeso y obesidad en adultos españoles. Nutr Hosp. 2011;26:355-63.

  7. Laux TS, Bert PJ, González M, Unruh M, Aragon A, Torres C. Prevalence of obesity, tobacco use, and alcohol consumption by socioeconomic status among six communities in Nicaragua. Rev Panam Salud Pública. 2012;32:217-25.

  8. Catarina E, Moreira R. Estimates of obesity trends in Brazil, 2006-2009. Internat J Public Health. 2012;57:127-33.

  9. Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG, Yang WY, et al. Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J. 2012;33:213-20.

  10. Domínguez Hernández LE, Alba Betancourt C. Efecto de la metformina sobre las pruebas de función hepática durante la obesidad. Verano de la Investigación Científica. 2015;1(2):292-6.

  11. Tébar Massó FJ, Garaulet Aza M, García Prieto MD. Regulación del apetito: nuevos conceptos. Rev Esp Obes. 2003;I(1):13-20.

  12. Chiquete E, Tolosa P. Conceptos tradicionales y emergentes sobre el balance energético. Revista de Endocrinología y Nutrición. 2013;21(2):59-68.

  13. Calzada-León R, Altamirano-Bustamante N, Ruiz-Reyes ML. Reguladores neuroendocrinos y gastrointestinales del apetito y la saciedad. Bol Med Hosp Infant Mex. 2008;65:468-87.

  14. Ochoa C. El intestino delgado, las incretinas y el metabolismo glucídico en la diabetes mellitus. Rev Cubana Aliment Nutr. 2012;22(2):301-13.

  15. Acosta-Hernández ME, Lozada-Sosa MC, Gasca-Pérez E, Ramos-Morales FR, Croda-Todd MT, Escobar-Henríquez JBH, et al. Hormonas del eje intestino-cerebro como sistema regulador del peso corporal y su relación con la obesidad. Revista Electrónica Medicina, Salud y Sociedad. 2015;5(3):280-95.

  16. Sato T, Nakamura Y, Shiimura Y, Ohgusu H, Kangawa K, Kojima M. Structure, regulation and function of ghrelin. Journal of Biochemistry. 2012;151:119-28.

  17. Acosta-Hernández ME, Gasca-Pérez E, Ramos-Morales FR, García-Rodríguez RV, Solís-Páez F, Evaristo-Portilla G, et al. Factores, causas y perspectivas de la obesidad infantil en México. Revista de los Estudiantes de Medicina de la Universidad Industrial de Santander. 2013;26(1):59-68.

  18. Sam AH, Troke RC, Tan TM, Bewick GA. The role of the gut/brain axis in modulating food intake. Neuropharmacology. 2012;63(1):46-56.

  19. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. Journal of Comparative and Physiological Psychology. 1973;84(3):488-95.

  20. Fromentin G, Darcel N, Chaumontet C, Marsset-Baglieri A, Nadkarni N, Tomé D. Peripheral and central mechanisms involved in the control of food intake by dietary amino acids and proteins. Nutr Res Rev. 2012;29:1-11.

  21. Wen D, Ma CL, Zhang YJ, Meng YX, Ni ZY, Li SJ, Cong B. Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence. BMC Neurosci. 2012;13(1):63.

  22. González-Jiménez E, Schmidt Río-Valle J. Regulación de la ingesta alimentaria y del balance energético; factores y mecanismos implicados. Nutr Hosp. 2012;27(6):1850-9.

  23. Feliciano Alfonso JE, Sierra Ariza ID. Nuevas terapias en diabetes: más allá de la insulina inyectable y de los antidiabéticos orales. Rev Assoc Med Bras. 2008;54(5):447-54.

  24. Pocai A. Unraveling oxyntomodulin, GLP1's enigmatic brother. Journal of Endocrinology. 2012;215:335-46.

  25. Bak MJ, Albrechtsen NJ, Pedersen J, Hartmann B, Christensen M, Vilsbøll T, et al. Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in human. European Journal of Endocrinology. 2014;170(4):529-38.

  26. Te Kamp V, Linder R, Jahne HG, Krinke KB, Kostelnik KB, Beck-Sickinger AG, et al. Quantitative impedimetric NPY-receptor activation monitoring and signal pathway profiling in living cells. Biosensors and Bioelectronics. 2014;67:386-93.

  27. Rojas I, Novials A. Amilina: del estudio molecular a las acciones fisiológicas. Endocrinología y Nutrición. 2001;48(8):234-45.

  28. Holzer P, Reichmann F, Farzi A. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides. 2012;46:261-74.

  29. Perry B, Wang Y. Appetite regulation and weight control: the role of gut hormones. Nutrition and Diabetes. 2012;2:e26.




2020     |     www.medigraphic.com